First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

BackgroundFirst-line treatment strategies for programmed death-ligand 1 (PD-L1) negative non-small cell lung cancer (NSCLC) patients include chemotherapy and combination with anti-angiogenesis drugs and/or immune checkpoint inhibitor. We conducted a Bayesian network meta-analysis to evaluate the eff...

Full description

Bibliographic Details
Main Authors: Ling Peng, Wen-Hua Liang, De-Guang Mu, Song Xu, Shao-Dong Hong, Justin Stebbing, Fei Liang, Yang Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
programmed death-ligand 1
non-small cell lung cancer
immune checkpoint inhibitor
network meta-analysis
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.657545/full

Similar Items

Similar Items